Clinical Trials Browser

Phase 1 × Neuroblastoma × MAGEA3 protein, human × Clear all

NCT00944580 2017-11-24

A Vaccine Study for High Risk Cancers

Phase 1 Withdrawn

Neuroblastoma, Rhabdomyosarcoma, Osteosarcoma